Britain’s Indivior Plc, which is also evaluating a long-acting injectable in a late-stage study, received the U.S. FDA’s fast-track status on Thursday (5/26) for the treatment.
Pages: 1 2 | Single Page
Britain’s Indivior Plc, which is also evaluating a long-acting injectable in a late-stage study, received the U.S. FDA’s fast-track status on Thursday (5/26) for the treatment.
Pages: 1 2 | Single Page
No Responses to “U.S. FDA Approves First-Ever Implant to Treat Opioid Addiction”